Group 1 - The core stock price of Helit Technology (603917) closed at 13.65 yuan as of July 4, 2025, up 4.12% from the previous week [1] - The company's total market capitalization is 2.782 billion yuan, ranking 199th out of 229 in the automotive parts sector and 4425th out of 5149 in the A-share market [1] - The highest intraday price reached 13.98 yuan on July 3, while the lowest was 13.12 yuan on June 30 [1] Group 2 - Helit Technology received a government subsidy of 2 million yuan, which accounts for 17.79% of the audited net profit attributable to shareholders for the fiscal year 2024, positively impacting the net profit for 2025 [1][3] - The company’s board and supervisory board approved the use of up to 400 million yuan of idle raised funds for cash management, aiming to enhance fund utilization efficiency and increase returns for the company and its shareholders [1][3] - The cumulative return from the entrusted financial management of raised funds over the past twelve months is 6.6745 million yuan, with a maximum single-day investment amount of 418 million yuan [1] Group 3 - The entrusted financial management involves China Industrial and Commercial Bank with an investment of 40 million yuan for a term of 100 days [4] - Additionally, China Bank's Xiangshan branch is entrusted with amounts of 28.42 million yuan and 29.58 million yuan, with investment terms of 178 days and 180 days respectively [4]

公司公告汇总 【公司公告汇总】本统计区间内未购买新理财产品，也无赎回情况。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年7月4日收盘，华翔股份（603112）报收于17.89元，较上周的16.9元上涨5.86%。本周，华翔 股份7月4日盘中最高价报19.02元，股价触及近一年最高点。7月1日盘中最低价报16.41元。华翔股份当 前最新总市值96.46亿元，在家电零部件板块市值排名5/31，在两市A股市值排名1679/5149。 关于使用部分闲置募集资金进行现金管理的进展及赎回公告：本统计区间为2025年6月1日至2025年6月 30日，期间未购买新理财产品，也无赎回情况。公司此前决议对总额不超过人民币1.80亿元的闲置募集 资金和不超过人民币2.00亿元的暂时闲置可转债募集资金进行现金管理。截至统计期末日，过去12个月 内公司购买国债逆回购单日最高投入金额为16345.20万元，实际产生收益201.46万元，目前未到期金额 为4343.70万元。其他理财产品方面，收益凭证实际投入4000万元，已全部收回本金并获得4 ...

Core Points - The company has completed the cancellation of certain special accounts for raised funds from its initial public offering and private placement [1][5][6] Fundraising Overview - The company raised a total of RMB 2,103,205,258.00 from its initial public offering, with a net amount of RMB 1,986,567,781.57 after deducting issuance costs [1] - The company also raised RMB 1,795,886,744.00 from a private placement, resulting in a net amount of RMB 1,773,446,130.53 after deducting issuance costs of RMB 22,440,613.47 [2] Fund Management - The company has established a management method for the use of raised funds, ensuring compliance with relevant laws and regulations, and has implemented special account management for the funds [3] Account Cancellation Details - The company has canceled several fundraising special accounts due to minimal remaining balances, transferring the remaining funds to other operational accounts [5] - The cancellation of these accounts has been completed, and the corresponding storage supervision agreements have been terminated [6]

Core Viewpoint - Ningbo Tianyi Medical Instrument Co., Ltd. has announced a change in the use of raised funds, terminating the original project for the "Comprehensive R&D Center Construction Project" and reallocating the remaining funds to the new "Thailand Production Base Construction Project" [1][2]. Fundraising Basic Information - The company raised a total of RMB 771.77 million by issuing 14.7368 million shares at RMB 52.37 per share, with net proceeds amounting to RMB 694.56 million after deducting various fees [1]. - The funds were verified by Lixin Accounting Firm, which issued a verification report [1]. Fundraising Special Account and Supervision Agreement - The company has established a special fundraising account at Shanghai Pudong Development Bank, Ningbo High-tech Zone Branch, for the new project [2][3]. - The company has signed a tripartite supervision agreement with the bank and its sponsor, Guotai Junan Securities, to oversee the use of the raised funds [3][4]. Tripartite Supervision Agreement Key Points - The special accounts for RMB and USD have been established, with balances of RMB 108.29 million and USD 0 as of July 2, 2025 [4]. - The funds in these accounts are exclusively for the "Thailand Production Base Construction Project" and cannot be used for other purposes [4]. - The sponsor has the right to supervise the use of funds and can conduct on-site investigations and inquiries [5][6]. - Any withdrawal exceeding RMB 20 million within a 12-month period must be reported to the sponsor [6].

募集资金使用管理办法 （2025 年 7 月） 第一章 总则 第一条 为了规范山东新潮能源股份有限公司（以下简称"公司"） 募集资金的使用和管理，提高募集资金使用效益，切实保护投资者的 利益，根据《中华人民共和国公司法》、《中华人民共和国证券法》、 《上市公司证券发行注册管理办法》、《上海证券交易所股票上市规 则》和《上海证券交易所上市公司自律监管指引第 1 号——规范运 作》等有关法律法规、规范性文件和公司章程的规定，结合公司的实 际情况，制定本管理办法。 第二条 本办法所指募集资金是指公司通过发行股票及其衍生 品种，向投资者募集并用于特定用途的资金；超募资金是指实际募集 资金净额超过计划募集资金金额的部分。 第三条 公司董事和高级管理人员应当勤勉尽责，督促公司规范 使用募集资金，自觉维护公司募集资金安全，不得参与、协助或纵容 公司擅自或变相改变募集资金用途。 第四条 公司控股股东、实际控制人及其他关联人不得直接或者 间接占用或者挪用公司募集资金，不得利用公司募集资金及募集资金 投资项目（以下简称"募投项目"）获取不正当利益。 第五条 募投项目通过公司的子公司或公司控制的其他企业实 施的，公司应当确保该子公 ...

申万宏源证券承销保荐有限责任公司 关于杭州光云科技股份有限公司 使用部分闲置募集资金临时补充流动资金的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"、"保 荐机构"）作为杭州光云科技股份有限公司（以下简称"光云科技"或"公司"）2022 年度以简易程序向特定对象发行股票的保荐机构，根据《证券发行上市保荐业务 管理办法》《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自 律监管指引第 1 号——规范运作》等有关规定，对光云科技使用部分闲置募集资 金临时补充流动资金的情况进行核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可〔2023〕306 号文核准，公司向特定对 象发行人民币普通股（A 股）24,824,684.00 股，发行价格为每股人民币 7.13 元， 募集资金总额为人民币 176,999,996.92 元，扣除发行费用（不含增值税）人民币 年 2 月 27 日全部到账，立信会计师事务所（特殊普通合伙）对公司以简易程序 向特定对象发行股票的资金到位情况进行了审验，并出具《验资报告》（信会师 报字2023第 ZF10072 号）。 （www.s ...

Core Points - The article discusses the completion of certain fundraising projects by Ninebot Limited and the decision to permanently supplement working capital with surplus funds raised from the issuance of depositary receipts [1] Fundraising Overview - Ninebot Limited raised a total of RMB 1,240,855,997.22 from the issuance of depositary receipts, after deducting issuance costs of RMB 92,693,682.58 [1] - The issuance was completed on October 23, 2020, with a total of 70,409,170 depositary receipts issued at a price of RMB 18.94 each [1] Project and Fund Usage - As of June 30, 2025, the cumulative investment in the fundraising projects was RMB 1,184,601,533.27, representing 95% of the total committed investment [1] - The project "Intelligent Delivery Robot R&D and Industrialization Development" has reached a usable state, leading to the conclusion of this fundraising project [1] Surplus Fund Reasons and Usage - The surplus funds were generated due to prudent management and cost control during the project execution, allowing for effective resource allocation [1] - The company plans to transfer the surplus funds of RMB 18,751,900 to its own account to permanently supplement working capital for daily operations [1] Approval and Opinions - The board of directors approved the proposal to conclude the fundraising project and use the surplus funds for working capital [1] - Independent directors confirmed that this decision benefits the company and all depositary receipt holders, ensuring no harm to the interests of minority shareholders [1] - The sponsor institution, Guotai Junan Securities, found no issues with the process and confirmed compliance with relevant regulations [1]

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and the management of raised funds by Shanghai Sinan Navigation Technology Co., Ltd. for the year 2024, detailing the total amount raised, its allocation, and compliance with regulatory requirements. Fundraising Overview - The company raised a total of RMB 784.77 million through its initial public offering, with a net amount of RMB 785.11 million after deducting issuance costs [1][2] - The funds are stored in dedicated accounts as per regulatory requirements, ensuring investor protection [1][2] Fund Usage and Balance - As of December 31, 2024, the remaining balance of the raised funds was RMB 406.91 million [3] - The company utilized RMB 21.20 million for various projects during the year, with a total of RMB 32.27 million being reallocated for different uses [6][7] - The company has not used idle funds for temporary working capital during the year [6][7] Fund Management and Compliance - The company has established a strict fund management system in accordance with relevant laws and regulations, ensuring proper storage, usage, and oversight of the raised funds [1][2] - The company has signed tripartite supervision agreements with banks to ensure compliance with fund management practices [2][3] Investment Projects - The company has invested in several projects, including the "New Generation High-Precision PNT Technology Upgrade and Industrialization Project," with a total investment of RMB 27.95 million [7] - The marketing network construction project has been delayed until June 5, 2026, to align with the current fundraising investment project implementation progress [6][7] Use of Excess Funds - The company has used RMB 40.38 million of excess funds for permanent working capital supplementation, accounting for 30% of the total excess funds [6][7] - A total of RMB 29.57 million has been used for share repurchase, with the repurchase price ranging from RMB 28.47 to RMB 41.03 per share [6][7] Audit and Verification - The report includes verification from the accounting firm, confirming that the fundraising and usage practices comply with regulatory requirements [6][7]

Summary of Key Points Core Viewpoint The company, Opcon Vision Technology Co., Ltd., is changing part of its fundraising purpose to acquire a 75% stake in Suqian Shangyue Qicheng Hospital Management Co., Ltd. This strategic move aims to enhance operational efficiency and align with the company's long-term development goals. Group 1: Fundraising and Financial Overview - The actual amount raised from the stock issuance was RMB 149,406.89 million after deducting issuance costs, with funds received in June 2022 [2][3]. - As of December 31, 2024, the company has utilized RMB 39,677.38 million of the raised funds, with a remaining balance of RMB 12,726.07 million after accounting for interest and investment income [3][4]. - The company plans to redirect RMB 23,373.00 million from the "Community Optical Service Terminal Construction Project" to fund the acquisition of Shangyue Qicheng [4][5]. Group 2: Acquisition Details - The total investment for acquiring a 75% stake in Shangyue Qicheng is RMB 33,390.00 million, with RMB 23,373.00 million sourced from the raised funds and RMB 10,017.00 million from the company's own funds [5][9]. - The acquisition aligns with the company's dual-driven development strategy of "full optical products + all-age optical services," enhancing its market presence in Yunnan Province [7][8]. - Shangyue Qicheng has established a comprehensive operational system and possesses strong brand recognition and profitability potential in the region [7][12]. Group 3: Financial Performance and Projections - Shangyue Qicheng's audited financial data shows total assets of RMB 11,073.59 million and net assets of RMB 6,151.34 million as of the latest report [14]. - The company has committed to achieving specific net profit targets from 2025 to 2029, with a minimum of RMB 3,900 million in 2025 [24]. - Future revenue growth is projected based on the expansion of service offerings and market penetration strategies, with a focus on medical services and optical products [21][22].

Group 1 - The company held its 13th meeting of the 10th Supervisory Board on July 4, 2025, via video communication, with all three supervisors present, ensuring compliance with relevant laws and regulations [1][2] - The Supervisory Board approved the proposal to use raised funds to replace self-raised funds previously invested in projects and to cover issuance expenses, totaling 965.415 million yuan and 523,600 yuan respectively, amounting to a total of 965.9386 million yuan [1][2] - The board also approved the proposal to deposit the remaining raised funds in the form of agreed deposits and notice deposits, confirming that this does not change the purpose of the raised funds or harm the interests of shareholders, particularly minority shareholders [2]